Credit: Getty Images. Researchers evaluated liver test abnormalities in patients hospitalized with COVID-19 and assessed cytokine levels in individuals with vs without abnormal test results.
Biotech Orpheris has been given the FDA go-ahead for a phase 2 aimed at calming the cytokine storm sometimes caused by COVID-19. The biotech hopes its therapy can help those with the disease who are ...
Researchers have identified a blood profile that could help identify COVID-19 patients at greatest risk of deterioration and direct them towards trials of specific treatments that could modify their ...
LOS ANGELES & CHICAGO--(BUSINESS WIRE)--Professor Frederick Behm, Head of the University of Illinois College of Medicine at Chicago Department of Pathology, and Dr. Bruce Gillis, CEO of EpicGenetics, ...
A big flush of funding from the National Institute for Health Research (NIHR) in the United Kingdom is pushing new research on ways to diagnose and treat long COVID. A University of Cambridge team ...
The job of your immune system is to protect your body from harmful foreign substances and keep you healthy. But sometimes your immune system does your body more harm than good. A cytokine storm occurs ...
People often get immunotherapy as a treatment for cancer. These immunotherapy treatments can be effective, but they may cause your immune system to have an unnatural response. Your body, as a result ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--ImmusanT, Inc., a clinical-stage company developing Nexvax2®, a therapeutic vaccine being investigated to protect against the effects of gluten in HLA-DQ2.5+ ...
Goal is to advance new combined blood purification technologies to treat Gram negative sepsis – a deadly global killer PRINCETON, N.J., Oct. 31, 2022 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback